Suguna Devi Sakkiah

Dr. Suguna Devi Sakkiah

US Food & Drug Administration (FDA) Natl Ctr Toxicol Res JEFFERSON, AR, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
WGWenjing Guo
Wenjing Guo
BPBohu Pan
Bohu Pan
SSSuguna Devi Sakkiah
Suguna Devi Sakkiah
GYGokhan Yavas
Gokhan Yavas
WGWeigong Ge
Weigong Ge
HHHuixiao Hong
Huixiao Hong
Persistent organic pollutants (POPs) present in foods have been a major concern for food safety due to their persistence and toxic effects. To ensure food safety and protect human health from POPs, it is critical to achieve a better understanding of POP pathways into food and develop strategies to reduce human exposure. POPs could present in food in the raw stages, transferred from the environment or artificially introduced during food preparation steps. Exposure to these pollutants may cause various health problems such as endocrine disruption, cardiovascular diseases, cancers, diabetes, birth defects, and dysfunctional immune and reproductive systems. This review describes potential sources of POP food contamination, analytical approaches to measure POP levels in food and efforts to control food contamination with POPs.

1 November 2015 in Cell Reports
Verified
Journal Article
Open access
BHBingchen Han
Bingchen Han
YQYing Qu
Ying Qu
YJYanli Jin
Yanli Jin
YYYi Yu
Yi Yu
NDNan Deng
Nan Deng
XCXiaojiang Cui
Xiaojiang Cui
The mesoderm- and epithelial-mesenchymal transition-associated transcription factor FOXC1 is specifically overexpressed in basal-like breast cancer (BLBC), but its biochemical function is not understood. Here, we demonstrate that FOXC1 controls cancer stem cell (CSC) properties enriched in BLBC cells via activation of Smoothened (SMO)-independent Hedgehog (Hh) signaling. This non-canonical activation of Hh is specifically mediated by Gli2. Furthermore, we show that the N-terminal domain of FOXC1 (aa 1-68) binds directly to an internal region (aa 898-1168) of Gli2, enhancing the DNA-binding and transcription-activating capacity of Gli2. FOXC1 expression correlates with that of Gli2 and its targets in human breast cancers. Moreover, FOXC1 overexpression reduces sensitivity to anti-Hedgehog (Hh) inhibitors in BLBC cells and xenograft tumors. Together, these findings reveal FOXC1-mediated non-canonical Hh signaling that determines the BLBC stem-like phenotype and anti-Hh sensitivity, supporting inhibition of FOXC1 pathways as potential approaches for improving BLBC treatment.

1 June 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SSSuguna Devi Sakkiah
Suguna Devi Sakkiah
STSundarapandian Thangapandian
Sundarapandian Thangapandian
SJShalini John
Shalini John
YKYong Jung Kwon
Yong Jung Kwon
KLKeun Woo Lee
Keun Woo Lee

15 February 2011 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
SJShalini John
Shalini John
STSundarapandian Thangapandian
Sundarapandian Thangapandian
SSSuguna Devi Sakkiah
Suguna Devi Sakkiah
KLKeun Woo Lee
Keun Woo Lee
Beta-site amyloid precursor protein cleaving enzyme (BACE-1) is a single-membrane protein belongs to the aspartyl protease class of catabolic enzymes. This enzyme involved in the processing of the amyloid precursor protein (APP). The cleavage of APP by BACE-1 is the rate-limiting step in the amyloid cascade leading to the production of two peptide fragments Aβ40 and Aβ42. Among two peptide fragments Aβ42 is the primary species thought to be responsible for the neurotoxicity and amyloid plaque formation that lead to memory and cognitive defects in Alzheimer’s disease (AD). AD is a ravaging neurodegenerative disorder for which no disease-modifying treatment is currently available. Inhibition of BACE-1 is expected to stop amyloid plaque formation and emerged as an interesting and attractive therapeutic target for AD.

29 March 2011 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
KSKh. Dhanachandra Singh
Kh. Dhanachandra Singh
Kirubakaran PalaniKirubakaran Palani
Kirubakaran Palani
SNShanthi Nagarajan
Shanthi Nagarajan
SSSuguna Devi Sakkiah
Suguna Devi Sakkiah
KMKarthikeyan Muthusamy
Karthikeyan Muthusamy
JJJeyaraman Jeyakanthan​
Jeyaraman Jeyakanthan​

1 October 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
STSundarapandian Thangapandian
Sundarapandian Thangapandian
SJShalini John
Shalini John
SSSuguna Devi Sakkiah
Suguna Devi Sakkiah
KLKeun Woo Lee
Keun Woo Lee